SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
227 hedge funds and large institutions have $308M invested in Sorrento Therapeutics, Inc. in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 47 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
227
Holders Change
-6
Holders Change %
-2.58%
% of All Funds
3.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
77
Reduced
47
Closed
26
Calls
$11.4M
Puts
$3.47M
Net Calls
+$7.88M
Net Calls Change
-$2.78M
Top Buyers
| 1 |
BlackRock
New York
|
+$24M |
| 2 |
State Street
Boston,
Massachusetts
|
+$11.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.83M |
| 5 |
Citigroup
New York
|
+$2.7M |
Top Sellers
| 1 |
Marshall Wace
London,
United Kingdom
|
-$3.86M |
| 2 |
D.E. Shaw & Co
New York
|
-$2.73M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.07M |
| 5 |
Two Sigma Investments
New York
|
-$1.58M |
